Low radon exposures and lung cancer risk: joint analysis of the Czech, French, and Beaverlodge cohorts of uranium miners.


Journal

International archives of occupational and environmental health
ISSN: 1432-1246
Titre abrégé: Int Arch Occup Environ Health
Pays: Germany
ID NLM: 7512134

Informations de publication

Date de publication:
07 2019
Historique:
received: 23 07 2018
accepted: 23 01 2019
pubmed: 10 2 2019
medline: 21 12 2019
entrez: 10 2 2019
Statut: ppublish

Résumé

It is well established that high radon exposures increase the risk of lung cancer mortality. The effects of low occupational exposures and the factors that confound and modify this risk are not clear and are needed to inform current radiation protection of miners. The risk of lung cancer mortality at low radon exposures (< 100 working-level months) was assessed in the joint cohort analysis of Czech, French, and Canadian uranium miners, employed in 1953 or later. Statistical analysis was based on linear Poisson regression modeling with grouped cohort survival data. Two sensitivity analyses were used to assess potential confounding from tobacco smoking. A statistically significant linear relationship between radon exposure and lung cancer mortality was found. The excess relative risk per working-level month was 0.022 (95% confidence intervals: 0.013-0.034), based on 408 lung cancer deaths and 394,236 person-years of risk. Time since exposure was a statistically significant modifier; risk decreased with increasing time since exposure. A tendency for a decrease in risk with increasing attained age was observed, but this was not statistically significant. Exposure rate was not found to be a modifier of the excess relative risk. The potential confounding effect of tobacco smoking was estimated to be small and did not substantially change the radon-lung cancer mortality risk estimates. This joint cohort analysis provides strong evidence for an increased risk of lung cancer mortality from low occupational radon exposures. The results suggest that radiation protection measures continue to be important among current uranium miners.

Identifiants

pubmed: 30737558
doi: 10.1007/s00420-019-01411-w
pii: 10.1007/s00420-019-01411-w
pmc: PMC6556158
doi:

Substances chimiques

Uranium 4OC371KSTK
Radon Q74S4N8N1G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-762

Références

Health Phys. 1991 Apr;60(4):489-95
pubmed: 2001944
Health Phys. 2013 Mar;104(3):282-92
pubmed: 23361424
Int Arch Occup Environ Health. 2015 Aug;88(6):717-30
pubmed: 25410273
Radiat Res. 2012 Mar;177(3):288-97
pubmed: 22206233
Health Phys. 2007 Apr;92(4):371-8
pubmed: 17351502
Radiat Res. 1997 Feb;147(2):126-34
pubmed: 9008203
Radiat Environ Biophys. 2009 Feb;48(1):1-9
pubmed: 18949479
Radiat Res. 2011 Sep;176(3):375-87
pubmed: 21714633
Epidemiology. 2011 Jan;22(1):90-7
pubmed: 20975563
BMJ Open. 2013 Feb 27;3(2):
pubmed: 23449746
Int J Environ Res Public Health. 2013 Mar 07;10(3):963-79
pubmed: 23470882
Epidemiology. 2015 Mar;26(2):204-12
pubmed: 25536456
Occup Environ Med. 2007 Oct;64(10):681-7
pubmed: 17449560
Radiat Res. 2008 Feb;169(2):125-37
pubmed: 18220460
Occup Environ Med. 2015 Jul;72(7):536-42
pubmed: 25713154
Health Rep. 2013 Aug;24(8):3-13
pubmed: 24258322
Am J Epidemiol. 2000 Mar 15;151(6):554-65
pubmed: 10733037
IARC Sci Publ. 1987;(82):1-406
pubmed: 3329634
Br J Cancer. 2015 Nov 3;113(9):1367-9
pubmed: 26393888
IARC Monogr Eval Carcinog Risks Hum. 2014;105:9-699
pubmed: 26442290
Health Phys. 2010 Jan;98(1):20-8
pubmed: 19959947
Occup Environ Med. 2005 May;62(5):325-9
pubmed: 15837854
J Radiol Prot. 2018 Mar;38(1):92-108
pubmed: 28925920
Health Phys. 2007 Feb;92(2):157-69
pubmed: 17220717
Am J Epidemiol. 2009 Mar 15;169(6):718-30
pubmed: 19208723
Ann Epidemiol. 2004 Oct;14(9):633-9
pubmed: 15380793
Am J Ind Med. 2007 Mar;50(3):199-207
pubmed: 17096363
Occup Environ Med. 2005 Feb;62(2):101-4
pubmed: 15657191
Occup Environ Med. 2016 Dec;73(12):838-845
pubmed: 27651479
Radiat Res. 2007 Dec;168(6):757-63
pubmed: 18088178
Ann ICRP. 2010 Feb;40(1):1-64
pubmed: 22108246
Eur J Epidemiol. 2004;19(2):139-46
pubmed: 15074570
Radiat Prot Dosimetry. 2015 Apr;164(1-2):147-53
pubmed: 25267854
Am J Epidemiol. 2000 Feb 15;151(4):384-95
pubmed: 10695597
Epidemiology. 2012 Nov;23(6):892-9
pubmed: 23007044
Radiat Res. 2010 Dec;174(6):773-85
pubmed: 21128801
Radiat Res. 2010 Jan;173(1):79-90
pubmed: 20041762
Int J Cancer. 2008 Jan 1;122(1):155-64
pubmed: 17893872
Radiat Prot Dosimetry. 2011 May;145(2-3):238-42
pubmed: 21471126
Radiat Res. 2011 Dec;176(6):796-806
pubmed: 21936607
Radiat Res. 2018 Feb;189(2):165-176
pubmed: 29215327
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11-465
pubmed: 23189751
Health Phys. 2009 Dec;97(6):613-21
pubmed: 19901596
Ann Intern Med. 1978 Mar;88(3):424-6
pubmed: 629506
Am J Epidemiol. 2004 Aug 15;160(4):384-92
pubmed: 15286024
J Radiol Prot. 2012 Sep;32(3):301-14
pubmed: 22809823
Epidemiology. 2015 Mar;26(2):213-5
pubmed: 25643100
Ann ICRP. 2017 Dec;46(3-4):1-486
pubmed: 29380630

Auteurs

Rachel S D Lane (RSD)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada. rachel.lane@canada.ca.
Directorate of Environmental and Radiation Protection and Assessment (DERPA), Canadian Nuclear Safety Commission (CNSC), 280 Slater Street, Station B, P.O. Box 1046, Ottawa, ON, K1P 5S9, Canada. rachel.lane@canada.ca.

Ladislav Tomášek (L)

National Radiation Protection Institute (SURO), Bartoskova 28, 140 00, Prague, Czech Republic.

Lydia B Zablotska (LB)

Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, 550 16th St, San Francisco, CA, 94158, USA.

Estelle Rage (E)

Institute for Radiological Protection and Nuclear Safety, B.P. 17, 92262, Fontenay-aux-Roses Cedex, France.

Franco Momoli (F)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.
Centre for Practice-Changing Research (Room L1152), Ottawa Hospital Research Institute, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Rd, Ottawa, ON, K1H 8L1, Canada.

Julian Little (J)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH